AlphaCentric Advisors’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$124K Buy
+311
New +$88.5K 0.1% 222
2024
Q2
Sell
-297
Closed -$103K 238
2024
Q1
$103K Sell
297
-40
-12% -$15.2K 0.06% 187
2023
Q4
$154K Sell
337
-37
-10% -$18.2K 0.1% 133
2023
Q3
$182K Sell
374
-51
-12% -$24K 0.1% 157
2023
Q2
$190K Buy
+425
New +$214K 0.11% 154
2021
Q4
Sell
-305
Closed -$119K 245
2021
Q3
$119K Hold
305
0.03% 152
2021
Q2
$135K Buy
305
+38
+14% +$16.6K 0.04% 149
2021
Q1
$112K Sell
267
-9
-3% -$3.59K 0.04% 140
2020
Q4
$113K Buy
+276
New +$115K 0.05% 111

Other funds holding HUM

AlphaCentric Advisors's HUM Position: Q2 2026 in Review

AlphaCentric Advisors opened a new position in Humana (HUM) in Q2 2026: 311 shares worth $124K. The stake represents 0.1% of the portfolio and ranks #222 among its holdings. This is a return to the name: AlphaCentric Advisors previously reported a position in HUM as recently as Q1 2024.

AlphaCentric Advisors first reported a position in HUM in Q4 2020 and has held it in 9 quarters since. The position peaked at $190K in Q2 2023. 925 funds tracked by Wall St. Rank hold HUM as of Q2 2026.

  • AlphaCentric Advisors held 311 shares of Humana worth $124K as of Q2 2026.
  • Humana was a new AlphaCentric Advisors position in Q2 2026.
  • Humana made up 0.1% of AlphaCentric Advisors's portfolio in Q2 2026, its #222 holding.
  • AlphaCentric Advisors first reported a position in Humana in Q4 2020 and has held it in 9 quarters since.
  • AlphaCentric Advisors's Humana position peaked at $190K in Q2 2023.
  • 925 funds tracked by Wall St. Rank held Humana as of Q2 2026.

Based on AlphaCentric Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.